New pill aims to help CMT patients walk farther in just 3 weeks
Symptom relief
Completed
This study tested an experimental drug called NMD670 in 81 adults with Charcot-Marie-Tooth disease types 1 and 2. Participants took either the drug or a placebo twice daily for 21 days. The main goal was to see if the drug helped them walk farther in a 6-minute test, and research…
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC